Publications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (68)

2025

  1. Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

    Journal of Hepatology, Vol. 83, Núm. 5, pp. 1102-1115

  2. Budget impact analysis of new drugs in oncology and haematology: Principles and practice

    British Journal of Clinical Pharmacology

  3. Correction to: Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing (Clinical and Translational Oncology, (2024), 27, 4, (1816-1825), 10.1007/s12094-024-03586-2)

    Clinical and Translational Oncology

  4. Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism

    European Journal of Internal Medicine, Vol. 137, pp. 67-72

  5. Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

    Clinical and Translational Oncology, Vol. 27, Núm. 1, pp. 175-181

  6. Immunotherapy in hepatocellular carcinoma

    Revisiones en Cancer, Vol. 39, Núm. 2, pp. 94-105

  7. Impact of COVID-19 in the incidence of venous thromboembolism (VTE) and clinical outcomes in cancer patients: a cohort study

    Clinical and Translational Oncology, Vol. 27, Núm. 2, pp. 756-769

  8. MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry

    ESMO Gastrointestinal Oncology, Vol. 8

  9. Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy

    ESMO Gastrointestinal Oncology

  10. PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group

    Clinical and Translational Oncology

  11. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing

    Clinical and Translational Oncology, Vol. 27, Núm. 4, pp. 1816-1825

2024

  1. Catheter – related thrombosis in cancer patients: Data from the registry of thrombosis and nEoplasia of SEOM (TESEO)

    Thrombosis Update, Vol. 17

  2. Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

    Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2388-2392

  3. Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain

    Clinical and Translational Oncology, Vol. 26, Núm. 6, pp. 1319-1328

  4. Thrombosis in breast cancer patients on cyclin-dependent kinase inhibitors: Survival impact and predictive factors - A study by the cancer and thrombosis group of the spanish society of medical oncology (SEOM)

    European Journal of Internal Medicine, Vol. 130, pp. 98-105

  5. Up and down in gastrointestinal cancer and bleeding with direct oral anticoagulants

    European Journal of Internal Medicine

  6. Update in venous thromboembolism in cancer: Lessons from multi-centre registries

    Thrombosis Update, Vol. 16

  7. Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

    Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177

2023

  1. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2911-2925

  2. Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive

    Internal and Emergency Medicine, Vol. 18, Núm. 6, pp. 1619-1634